Archives

by in
Entry Author Date Location
Xconomy Boston’s Top Stories of Q1 2014: Editor’s Picks 03/31/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More 12/13/13 Boston
Gilead Wins FDA Approval for Big Hepatitis C Drug 12/06/13 San Francisco
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More 09/06/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
U.S. Venture Activity Remains Steady as IPOs Rise in Second Quarter 07/16/13 National
Harvard Professor Steps Down to Pilot Warp Drive Bio 07/02/13 Boston
East Coast Biotech Roundup: Moderna, bluebird, Blueprint 03/22/13 Boston
Enanta, Tetraphase Go Public in Boston Biotech IPO Madness 03/21/13 Boston
Enanta, Satori, Vertex & More of the Week’s Life Sciences Newsmakers 02/24/12 Boston
GreatPoint, Enanta, NextView, & More Boston Dealmakers 02/22/12 Boston
Enanta Enters HepC Big Leagues, With $34M Upfront From Novartis 02/21/12 Boston
Biogen Idec Rebuts Icahn Attack, GlaxoSmithKline Quietly Spins Off Tempero Pharmaceuticals, Knome Launches Cheaper Sequencing Service, & More Boston-Area Life Sciences News 05/20/09 Boston
GSK biotech subsidiary Tempero Pharma launched in the Boston area 05/15/09 Boston
Millennium Enjoying New Era, Novartis Boosting Vaccine Effort, Living Proof Offering Frizz Fighters Online, & More Life Sciences News 09/17/08 Boston
Enanta Pharmaceuticals Starts Clinical Trial of Antibiotic for Drug Resistant Bacteria 09/15/08 Boston
Page 1 of 1